Skip to main content
SpringerLink
Log in

In vitro expansion and analysis of T lymphocyte microcultures obtained from the vaccination sites of cancer patients undergoing active specific immunization with autologous Newcastle-disease-virus-modified tumour cells

  • Original Articles
  • Active Specific Immunization, NDV-modified Tumour Cells, Microcultures, Tumour Vaccines
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Abstract

In order to understand further the effects of Newcastle-disease-virus(NDV)-modified tumour vaccines we investigated the feasibility of isolating lymphocytes from the site of injection of patients undergoing postoperative active specific immunization (ASI) with autologous NDV-modified tumour cells. Delayed-type-hypersensitivity(DTH)-like reactions from five cancer patients were surgically removed, minced and the tissue particles were digested with collagenase and DNase. Lymphoid cells recovered were expanded in a highly efficient limiting-dilution analysis system optimized for T cell growth [Moretta et al. (1983) J Exp Med 157: 743] and lymphocyte microcultures (clonal probability >0.8) could be grown for up to 1 year. Analysis of the microcultures for phenotype and function showed that the majority were positive for CD4 (92%) and TCRαβ (96%). Concanavalin-A-induced production of interleukin-2 (IL-2), IL-6, interferon γ and tumour necrosis factor α was detected in more than 70% of the microcultures. Lectin-dependent cytotoxicity was only very rarely observed. The general characteristics of the microcultures obtained support the notion of a DTH-like reaction taking place at the site of tumour cell challenge. The possibility of in vitro expansion and cultivation of T lymphocytes from ASI vaccination sites should help to elucidate further the role of these cells in active specific immunization against autologous tumour cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bier H, Armonat G, Bier J, Schirrmacher V, Ganzer U (1989) Postoperative active-specific immunotherapy of lymph node micrometastasis in a guinea pig tumor model. Otorhinolaryngology 51: 197

    Google Scholar 

  2. Bohle W, Schlag P, Liebrich W, Hohenberger P, Manasterski M, Müller P, Schirrmacher V (1990) Postoperative active specific immunization in colorectal cancer patients with virus-modified autologous tumor-cell vaccine: first clinical results with tumor cell vaccines modified with live but avirulent newcastle disease virus. Cancer 66: 1517

    PubMed  Google Scholar 

  3. Dvorak HF, Galli SJ, Dvorak AM (1986) Cellular and vascular manifestations of cell-mediated immunity. Hum Pathol 17: 122

    PubMed  Google Scholar 

  4. Fleischer B (1988) Non-specific propagation of human antigen-dependent T lymphocyte clones. J Immunol Methods 109: 215

    PubMed  Google Scholar 

  5. Foon KA (1989) Biological response modifiers: the new immunotherapy. Cancer Res 49: 1621

    PubMed  Google Scholar 

  6. Heicappell R, Schirrmacher V, von Hoegen P, Ahlert T, Appelhans B (1986) Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. I. parameters for optimal therapeutic effect. Int J Cancer 37: 569

    PubMed  Google Scholar 

  7. Ijzermans JN, Marquet RL (1989) Interferon-gamma: a review. Immunobiology 179: 456

    PubMed  Google Scholar 

  8. Lehner B, Schlag P, Liebrich W, Schirrmacher V (1990) Postoperative active specific immunization in curatively resected colorectal cancer patients with a virus-modified autologous tumor cell vaccine. Cancer Immunol Immunother 32: 173

    PubMed  Google Scholar 

  9. Liebrich W, Schlag P, Manasterski M, Lehner B, Stöhr M, Müller P, Schirrmacher V (1991) In vitro and clinical characterisation of a newcastle disease virus-modified autologous tumor cell vaccine for treatment of colorectal cancer patients. Eur J Cancer 27: 703

    PubMed  Google Scholar 

  10. Männel DN, Falk W (1989) Optimal induction of tumor necrosis factor production in human monocytes requires complete S-form lipopolysaccharide. Infect Immun 57: 1953

    PubMed  Google Scholar 

  11. Miescher S, Stoeck M, Qiao L, Barras C, Barrelet L, von Fliedner V (1988) Proliferative and cytolytic potentials of purified human tumor-infiltrating T-lymphocytes. Impaired response to mitogendriven stimulation despite T-cell receptor expression. Int J Cancer 42: 659

    PubMed  Google Scholar 

  12. Moretta A, Pantaleo G, Moretta L, Cerottini JC, Mingari MC (1983) Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity. J Exp Med 157: 743

    PubMed  Google Scholar 

  13. Rosenberg SA, Schwarz SL, Spiess PJ (1988) Combination immunotherapy for cancer: Synergistic antitumor interactions of interleukin-2, alpha interferon and tumor-infiltrating lymphocytes. JNCI 80: 1393

    PubMed  Google Scholar 

  14. Schirrmacher V (1993) Immunity and metastasis: in situ activation of protective T cells by virus modified cancer vaccines. Cancer Surv (in press)

  15. Schirrmacher V, Heicappel R (1987) Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. II. Establishment of specific systemic anti-tumor immunity. Clin Exp Metastasis 5: 147

    PubMed  Google Scholar 

  16. Schirrmacher V, Ahlert T, Heicappell R, Appelhans B, von Hoegen P (1986) Successful application of non-oncogenic viruses for antimetastatic cancer immunotherapy. Cancer Rev 5: 19

    Google Scholar 

  17. Schirrmacher V, von Hoegen P, Schlag P, Liebrich W, Lehner B, Schumacher K, Ahlert T, Bastert G (1989) Active specific immunotherapy with autologous tumor cell vaccines modified by Newcastle disease virus: experimental and clinical studies. In: Schirrmacher V, Schwartz-Albiez R (eds) Cancer metastasis. Springer, Berlin Heidelberg New York, pp 157–170

    Google Scholar 

  18. Shoham J, Hirsch R, Zakay-Rones Z, Osband M, Brennert HJ (1990) Augementation of tumor cell immunogenicity by viruses-an approach to specific immunotherapy of cancer. Nat Immun Cell Growth Regul 9: 165

    PubMed  Google Scholar 

  19. Stevenson HC, Foon KA, Kanapa DJ, Favilla T, Beman I, Oldham RK (1984) The potential value of cytapheresis for adoptive immuntherapy of cancer patients. Plasma Ther Transf Technol 5: 237

    Google Scholar 

  20. Weber E, Kees UR, Krammer P Computer analysis of data from limiting dilution experiments of cells of the immune system. DKFZ Research Monograph

  21. Whiteside TL, Miescher S, Hurlimann J, Moretta L, von Fliedner V (1986) Separation, phenotyping and limiting dilution analysis of T-lymphocytes infiltrating human solid tumors. Int J Cancer 37: 803

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. German Cancer Research Centre, Institut für Immunologie und Genetics, Heidelberg, Germany

    M. Stoeck, C. Marland-Noske & V. Schirrmacher

  2. Institute for Virus Research, German Cancer Research Centre, Heidelberg, Germany

    R. Zawatzky

  3. Section of Surgical Oncology, Department of Surgery, University of Heidelberg, Germany

    M. Manasterski & P. Schlag

  4. Department of Gynaecology and Obstetrics, University of Mainz, Germany

    S. Horn & V. Möbus

Authors
  1. M. Stoeck
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Marland-Noske
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Manasterski
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Zawatzky
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Horn
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. V. Möbus
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P. Schlag
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. V. Schirrmacher
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This study was supported by Dr.-Mildred-Scheel-Stiftung and the Tumorzentrum Heidelberg

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stoeck, M., Marland-Noske, C., Manasterski, M. et al. In vitro expansion and analysis of T lymphocyte microcultures obtained from the vaccination sites of cancer patients undergoing active specific immunization with autologous Newcastle-disease-virus-modified tumour cells. Cancer Immunol Immunother 37, 240–244 (1993). https://doi.org/10.1007/BF01518517

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01518517

Key words

Search

Navigation